K4 Elite logo K4 Elite
Home / Peptide Library / Triptorelin
FDA Approved

Triptorelin

Hormonal & Endocrine · Trelstar, Decapeptyl, Diphereline, D-Trp-6-LHRH, AY-25650

A long-acting GnRH agonist decapeptide studied in models of gonadotropin regulation and hypothalamic-pituitary-gonadal axis suppression.

🔬 Research use only — not for human or veterinary use. K4 Elite does not provide dosing instructions.
Molecular Formula
C64H82N18O13
Molecular Weight
1311.4 g/mol
PubChem
CID 25074470 ↗
Research Level
FDA Approved
Browse the store →
Triptorelin chemical structure

Triptorelin is a synthetic decapeptide analog of gonadotropin-releasing hormone (GnRH) in which the native glycine at position 6 is replaced by D-tryptophan. This single substitution increases receptor affinity and resistance to enzymatic degradation, producing a long-acting GnRH agonist.

It is widely studied as a tool for sustained modulation of the hypothalamic-pituitary-gonadal (HPG) axis and has an established regulatory history across multiple clinical indications.

Its well-defined pharmacology makes it a common reference agonist in reproductive endocrinology research.

Triptorelin binds the pituitary GnRH receptor as a potent agonist. Initial administration produces a transient rise in luteinizing hormone (LH) and follicle-stimulating hormone (FSH), often called the flare effect, in study models.

With continuous or sustained exposure, the GnRH receptor is downregulated and desensitized, leading to suppressed gonadotropin secretion and reduced gonadal steroid output, a mechanism extensively characterized in the reproductive-endocrinology literature.

  • Gonadotropin regulation — studied for the initial flare and subsequent suppression of LH and FSH [1].
  • HPG axis suppression — investigated for downregulation of GnRH receptors under sustained exposure [1].
  • Receptor desensitization — examined for the pharmacology of continuous agonist exposure [2].
  • Endocrine research models — explored in studies of steroid-hormone-dependent tissue [3].
  • Reproductive pharmacology — characterized as a reference long-acting GnRH agonist [2].
📋 How published studies were conducted — a research reference summarizing study designs from the literature. This is not usage, dosing, or administration guidance. K4 Elite does not provide dosing instructions; determining any research protocol is the sole responsibility of the qualified researcher.

In endocrine research, investigators administered triptorelin and measured the transient rise then sustained suppression of LH and FSH to characterize GnRH-receptor desensitization [1].

Pharmacology studies examined continuous versus pulsatile GnRH-agonist exposure and reported observations on receptor downregulation [2]. Additional studies evaluated triptorelin in models of steroid-hormone-dependent tissue and reported endocrine endpoints [3]. These are reported study observations, listed for reference only.

Combinations examined in the research literature. Descriptive only — not a recommendation to combine compounds.

GonadorelinNeutral
Native short-acting GnRH; contrasted with triptorelin to study pulsatile versus continuous receptor signaling.
Kisspeptin-10Neutral
Acts upstream of GnRH; studied as part of the same reproductive-axis framework.
LeuprolideNeutral
Another long-acting GnRH agonist; typically compared rather than combined in research.
TestosteroneCaution
Sustained GnRH-agonist exposure alters gonadal steroid output, relevant to study designs measuring steroids.
  1. Conn PM, Crowley WF, N Engl J Med 1991 (GnRH and analogs review)
  2. Millar RP et al., Endocr Rev 2004 (GnRH receptors and analogs)
  3. Kuhn JM et al., N Engl J Med 1989 (triptorelin endocrine effects)
What class of compound is triptorelin?
It is a long-acting synthetic GnRH agonist decapeptide, with D-tryptophan substituted at position 6 for stability and receptor affinity.
What is the flare effect?
Research describes an initial transient rise in LH and FSH on first exposure, followed by suppression as the GnRH receptor is downregulated.
What research areas has it been studied in?
Studies span gonadotropin regulation, HPG axis suppression, receptor desensitization, and steroid-hormone-dependent tissue models.
How does it differ from native GnRH?
A single D-amino acid substitution makes it far more stable and long-acting than native gonadorelin, producing sustained rather than pulsatile signaling.
Is this material intended for human use?
No. This entry describes a compound supplied strictly for in-vitro and laboratory research use only, not for human or veterinary use.
Disclaimer: This profile summarizes published preclinical and laboratory research for reference only. It is not medical advice and makes no claim of safety or efficacy in humans. Determining any research protocol is the sole responsibility of the qualified researcher. Products are sold strictly for in-vitro research and have not been evaluated by the FDA.